Skip to main content

New medicines advice for NHS Wales

Welsh Government has approved advice from the All Wales Medicines Strategy Group (AWMSG) for extending the use of a medicine.

Darunavir cobicistat (Rezolsta®) was recommended in combination with other HIV medicines for the treatment of HIV infection in adolescents aged 12 years to less than 18 years who weigh at least 40 kilograms.

Rezolsta® was recommended for use in adults for the treatment of HIV by AWMSG in 2015.

AWTTC’s Patient Access to Medicines Service (PAMS) supports the AWMSG to assess and monitor new medicines in Wales.